BIOMAT Database Logo BIOMAT Database Logo

Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance. 2021

Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA. wanghai@nanoctr.cn.

The transmembrane P-glycoprotein (P-gp) pumps that efflux drugs are a major mechanism of cancer drug resistance. They are also important in protecting normal tissue cells from poisonous xenobiotics and endogenous metabolites. Here, we report a fucoidan-decorated silica-carbon nano-onion (FSCNO) hybrid nanoparticle that targets tumor vasculature to specifically release P-gp inhibitor and anticancer drug into tumor cells. The tumor vasculature targeting capability of the nanoparticle is demonstrated using multiple models. Moreover, we reveal the superior light absorption property of nano-onion in the near infrared region (NIR), which enables triggered drug release from the nanoparticle at a low NIR power. The released inhibitor selectively binds to P-gp pumps and disables their function, which improves the bioavailability of anticancer drug inside the cells. Furthermore, free P-gp inhibitor significantly increases the systemic toxicity of a chemotherapy drug, which can be resolved by delivering them with FSCNO nanoparticles in combination with a short low-power NIR laser irradiation.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D002244 Carbon A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel. Carbon-12,Vitreous Carbon,Carbon 12,Carbon, Vitreous
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000082703 Photothermal Therapy Application of LOCAL HYPERTHERMIA within a specific tissue using electromagnetic radiation to convert light/laser into heat often coupled with PHOTOSENSITIZER including nanoparticle. Photothermal Therapies,Therapy, Photothermal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012822 Silicon Dioxide Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. Silica,Aerosil,Aerosil 380,Cristobalite,Quso G-32,Quso G32,Tridymite,380, Aerosil,Dioxide, Silicon,G32, Quso,Quso G 32
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell

Related Publications

Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.
September 2016, Expert opinion on drug metabolism & toxicology,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer.
February 2022, Nanomedicine : nanotechnology, biology, and medicine,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance.
January 2008, Current medicinal chemistry,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers.
October 2021, Cancers,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
January 2021, Medicinal research reviews,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux.
January 2007, Molecular pharmaceutics,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance.
March 2020, Future medicinal chemistry,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review.
September 2023, Pharmacology & therapeutics,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein.
October 2021, European journal of medicinal chemistry,
Hai Wang, and Yutong Liang, and Yue Yin, and Jie Zhang, and Wen Su, and Alisa M White, and Bin Jiang, and Jiangsheng Xu, and Yuntian Zhang, and Samantha Stewart, and Xiongbin Lu, and Xiaoming He
Novel modulators to overcome P-glycoprotein-mediated multidrug resistance in tumor cells.
November 2004, International journal of clinical pharmacology and therapeutics,
Copied contents to your clipboard!